Chek2 DNA Damage Response Pathway and Inherited Breast Cancer Risk
Authors:
- 1 October 2011
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (28) , 3813-3815
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- BRCA1 regulates human mammary stem/progenitor cell fateProceedings of the National Academy of Sciences, 2008
- Variation of Breast Cancer Risk Among BRCA1/2 CarriersJAMA, 2008
- Meta-Analysis of BRCA1 and BRCA2 PenetranceJournal of Clinical Oncology, 2007
- Chk2 Mediates Stabilization of the FoxM1 Transcription Factor To Stimulate Expression of DNA Repair GenesMolecular and Cellular Biology, 2007
- A Multicenter Study of Cancer Incidence in CHEK2 1100delC Mutation CarriersCancer Epidemiology, Biomarkers & Prevention, 2006
- Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaksJournal of Cell Biology, 2006
- ATM and Chk2‐dependent phosphorylation of MDMX contribute to p53 activation after DNA damageThe EMBO Journal, 2005
- Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast CancerJNCI: Journal of the National Cancer Institute, 2003
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002